Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
11/20/2014 | US20140343051 Methods to modulate acute myeloid leukemia stem/progenitor cell expansion and/or differentiation |
11/20/2014 | US20140343045 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof |
11/20/2014 | US20140343041 Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache |
11/20/2014 | US20140343037 Benzene, pyridine, and pyridazine derivatives |
11/20/2014 | US20140343021 Adjuvant to thrombolytic therapy for the treatment of frostbite |
11/20/2014 | US20140343014 Combination of a certain dpp-4 inhibitor and voglibose |
11/20/2014 | US20140343011 Methods for treating or preventing urological inflammation |
11/20/2014 | US20140343006 HIV Replication Inhibiting Pyrimidines |
11/20/2014 | US20140343003 Method for treating lyme disease |
11/20/2014 | US20140343000 Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
11/20/2014 | US20140342998 Quinone based nitric oxide donating compounds |
11/20/2014 | US20140342996 Treatments for Gastrointestinal Disorders |
11/20/2014 | US20140342994 Fusion Protein Comprising Circularly Permuted Form Of Trail/Apo2L, Coding Gene And Use Thereof |
11/20/2014 | US20140342989 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents |
11/20/2014 | US20140342987 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer |
11/20/2014 | US20140342405 Vascular endothelial growth factor 2 |
11/20/2014 | US20140342009 Boswellia oil, its fractions and compositions for enhancing brain function |
11/20/2014 | US20140341994 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
11/20/2014 | US20140341988 Orally dispersible drug formulations |
11/20/2014 | US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders |
11/20/2014 | US20140341979 Nanodrug targeting protein geranylgeranylation |
11/20/2014 | US20140341975 Pathogen and substance traps |
11/20/2014 | US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
11/20/2014 | US20140341937 Methods and Compositions for Modulating Immune Tolerance |
11/20/2014 | US20140341926 Method for egfr directed combination treatment of cancer |
11/20/2014 | US20140341923 Human Rhinovirus (HRV) Antibodies |
11/20/2014 | US20140341921 Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
11/20/2014 | US20140341913 Methods and compositions for treating asthma using anti-il-13 antibodies |
11/20/2014 | US20140341912 Monoclonal antibodies directed to cd52 |
11/20/2014 | US20140341901 Compositions and methods of use for antibodies of dickkopf-1 |
11/20/2014 | US20140341900 Methods of treating cancer |
11/20/2014 | US20140341886 TREATMENT WITH ANTI ErbB2 ANTIBODIES |
11/20/2014 | US20140341879 Methods for the prevention or treatment of vessel occlusion injury |
11/20/2014 | US20140341867 Treatment of stroke using isolated placental cells |
11/20/2014 | US20140341851 Novel benzimidazole derivatives |
11/20/2014 | US20140341850 Haloalkyl heteroaryl benzamide compounds |
11/20/2014 | US20140341849 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer |
11/20/2014 | US20140341848 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication |
11/20/2014 | US20140341847 4'-fluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication |
11/20/2014 | US20140341810 Antagonists for abdominal vasopressin v2 receptor and uses thereof |
11/20/2014 | US20140341804 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof |
11/20/2014 | US20140341802 Provasopressin antagonists and uses thereof |
11/18/2014 | US8889871 Hepatitis C virus inhibitors |
11/18/2014 | US8889736 Formulations for the treatment of pain |
11/18/2014 | US8889724 Tetrazole compounds for reducing uric acid |
11/18/2014 | US8889720 Non-flushing niacin analogues, and methods of use thereof |
11/18/2014 | US8889712 IAP antagonists |
11/18/2014 | US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C |
11/18/2014 | US8889707 Treatment of addiction |
11/18/2014 | US8889705 Noscapine analogs and their use in treating cancers |
11/18/2014 | US8889701 Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate |
11/18/2014 | US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
11/18/2014 | US8889691 Indole compounds as an inhibitor of cellular necrosis |
11/18/2014 | US8889689 Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer |
11/18/2014 | US8889669 Cytotoxic benzodiazepine derivatives |
11/18/2014 | US8889668 Oxadiazole diaryl compounds |
11/18/2014 | US8889659 Pain relief compositions, manufacture and uses |
11/18/2014 | US8889630 Method for hair regrowth using Granulocyte-Colony Stimulating Factor |
11/18/2014 | US8889621 Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia |
11/18/2014 | US8889615 Methods for promoting epithelialization and healing of chronic wounds |
11/18/2014 | US8889426 Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia |
11/18/2014 | US8889375 Hypoglycemic effect enhancer |
11/18/2014 | US8889194 Smoking cessation with body weight maintenance and nutritional supplement |
11/18/2014 | US8889188 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses |
11/18/2014 | US8889187 Once a day amoxicillin product comprising immediate and delayed release dosage forms |
11/18/2014 | US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes |
11/18/2014 | US8889175 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases |
11/18/2014 | US8889170 Implantable device having a coating with a triblock copolymer |
11/18/2014 | US8889153 Combination of immunomodulator and anti-pathogenic agent |
11/18/2014 | US8889152 Capsular polysaccharides solubilisation and combination vaccines |
11/18/2014 | US8889144 PCSK9 vaccine |
11/18/2014 | US8889134 Modulators of Candida hyphal morphogenesis and uses thereof |
11/18/2014 | US8889115 Ion binding polymers and uses thereof |
11/18/2014 | US8889112 Ophthalmic formulations including selective alpha 1 antagonists |
11/18/2014 | US8888736 High shear application in medical therapy |
11/18/2014 | US8887721 Attenuation of vasoactive oxygen carrier-induced vasoconstriction |
11/13/2014 | US20140336440 Inhibitors of rho associated protein kinases (rock) and methods of use |
11/13/2014 | US20140336359 Synthetic peptides for treatment of bacterial infections |
11/13/2014 | US20140336258 Anti-virulence compositions and methods |
11/13/2014 | US20140336248 Therapeutic compositions and related methods of use |
11/13/2014 | US20140336244 Methods and products for reawakening retrocyclins |
11/13/2014 | US20140336243 Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes |
11/13/2014 | US20140336240 Method of treating hyperlipidemia and atherosclerosis with mir-30c |
11/13/2014 | US20140336229 Pharmaceutical composition for preventing or treating hyperlipidemia |
11/13/2014 | US20140336228 Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases |
11/13/2014 | US20140336210 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
11/13/2014 | US20140336207 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
11/13/2014 | US20140336205 Small Molecule Xanthine Oxidase Inhibitors and Methods of Use |
11/13/2014 | US20140336204 Methods of inhibiting xanthine oxidase activity in a cell |
11/13/2014 | US20140336194 Method of treating contrast-induced nephropathy |
11/13/2014 | US20140336177 Inhibitors of the renal outer medullary potassium channel |
11/13/2014 | US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists |
11/13/2014 | US20140336171 Azaindoles useful as inhibitors of janus kinases |
11/13/2014 | US20140336168 Nampt inhibitors |
11/13/2014 | US20140336159 Methods for treating and diagnosing respiratory tract infections |
11/13/2014 | US20140336158 Nk1 antagonists |
11/13/2014 | US20140336148 Combinations of diacerein and non-steroidal inflammation drugs |
11/13/2014 | US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
11/13/2014 | US20140336138 Compositions and methods for screening and treatment of sturge-weber syndrome, klippel-trenaunay-weber syndrome, and port-wine stains (pwss) |
11/13/2014 | US20140336131 Methods for treating inflammation, autoimmune disorders and pain |